United Therapeutics has high revenue growth and low debt. Read why UTHR stock is undervalued with solid financial metrics and ...

The Los Angeles County Sheriff's Department will retest more than 4,000 DNA samples after announcing it used a faulty testing ...

In a medical first, a research team in China has successfully stitched a CRISPR gene-edited pig liver into a brain-dead ...

Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biotechnology company with clinical development programs focusing on organ fibrosis, today announced the publication ...

Regulus Therapeutics Inc.’s RGLS share price has surged by 16.28%, which has investors questioning if this is right time to ...

An organ procurement organization filed a lawsuit to stop Atrium Health from taking over organ donation services at Atrium ...

The battle over the health merits of various cooking fats has never really gotten below a simmer — but it’s starting to heat ...

It's early days for xenotransplantation, but eGenesis, Eledon, United Therapeutics and more are working to develop solutions ...

After raising an impressive 1.2 billion euros in 2024, European venture capital firm Sofinnova Partners is topping up its ...

SAN DIEGO, March 17, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), a self-sustainable, commercial-stage biotechnology company with clinical development programs focusing on organ ...